# Genomic Research Pipeline for Large-Scale Disease Risk Prediction  
### A Research-Oriented Technical Documentation

---

## Abstract
Whole-genome sequencing (WGS) has transformed biomedical research by enabling high-resolution characterization of genetic variation across global populations. However, the sheer scale, heterogeneity, and computational intensity of genomic datasets—often spanning terabytes of raw variant information—present significant challenges for downstream disease-risk prediction.  

This research develops a scalable Big Data and Machine Learning pipeline that processes 3–4 TB of variant call data from the 1000 Genomes Project, performs distributed quality control and functional annotation, and constructs polygenic risk–based disease prediction models. By integrating Spark-based distributed computing with XGBoost classification and Polygenic Risk Scoring (PRS), the pipeline demonstrates a robust framework for disease risk stratification at population scale.  

---

## 1. Introduction
Advances in genomic sequencing technologies have allowed biologists and clinicians to access unprecedented amounts of genetic information. Despite this progress, transforming raw variant data into clinically actionable disease-risk insights remains a major computational barrier. Conventional workflows cannot effectively scale to tens of millions of variants or thousands of whole-genome samples without encountering bottlenecks in storage, fragmentation, and computational throughput.

This project proposes a complete Big Data–driven research pipeline that integrates distributed variant processing, population stratification, functional annotation, polygenic modeling, and machine learning–based disease-risk prediction. The solution is architected for scalability, reproducibility, and biological interpretability.

---

## 2. Research Problem and Motivation

### 2.1 Problem Statement
Whole-genome datasets from projects like the 1000 Genomes Initiative contain:
- **3–4 TB of VCF files**
- **84+ million SNPs and indels**
- **Thousands of globally diverse individuals**

Extracting disease-relevant signals from such massive variant matrices is limited by:
- Slow and memory-intensive preprocessing tools  
- High dimensionality (p >> n)  
- Population stratification that biases predictions  
- The need for biologically interpretable models  

### 2.2 Research Motivation
Clinical applications require:
- scalable pipelines that handle terabyte-level data,
- biologically interpretable predictive features (e.g., PRS, GWAS signals),
- robust modeling strategies that mitigate population confounding.

This work addresses these needs by constructing a reproducible, high-performance genomic machine learning pipeline.

---

## 3. Dataset Description

### 3.1 Source
**1000 Genomes Project**  
- FTP and AWS Open Data mirrors  
- 2504 individuals across 26 ancestral populations  
- 84.4 million variants (SNPs + indels)  
- Format: **VCF**  
- Size: **3–4 TB**

### 3.2 Big Data Qualification
WGS variant files require:
- distributed compute clusters,  
- parallel chromosome-level processing, and  
- efficient columnar storage (Parquet) for downstream analysis.

Thus, a cloud-scale architecture is essential.

---

## 4. Big Data Pipeline Architecture

### 4.1 High-Level Pipeline Flow


### 4.2 Architecture Components (Rewritten Professionally)

#### **Raw Data Layer**
- Source: 1000 Genomes FTP  
- Storage: AWS S3 Raw Zone  
- Format: VCF (compressed)

#### **Processing Layer (Spark Cluster)**
- Distributed across ≥ 50 compute nodes  
- Chromosome-parallelized QC and filtering  
- High-memory nodes (256GB+) for variant manipulation  
- EBS-optimized for I/O-heavy workloads  

#### **Genomic Processing Layer**
- Variant Quality Control (MAF, HWE, call rate)  
- Sample QC (relatedness, ancestry outliers)  
- Annotation of functional impact (missense, regulatory, coding)  

#### **Feature Reduction Layer**
- Reduce 84M variants → ~10K biologically meaningful SNPs  
- Filters:
  - GWAS significance  
  - Functional relevance  
  - Minor allele frequency thresholds  

#### **Machine Learning & Interpretation Layer**
- PRS computation  
- XGBoost disease-risk prediction  
- Feature importance for pathways & gene-level interpretation  
- Risk stratification dashboards  

---

## 5. Genomic Processing Methodology

### 5.1 Variant Quality Control (Rewritten)
Quality control is applied at both the variant and sample levels:

**Variant-level QC**
- Call Rate > 95%  
- Minor Allele Frequency (MAF) > 1%  
- Hardy-Weinberg Equilibrium p-value > 1e-6  

**Sample-level QC**
- Remove related samples  
- Remove population outliers (via PCA)  
- Ensure high genotype completeness  

---

### 5.2 Pre-Processing Strategy

#### Handling Missing Data
- Mode imputation for genotype calls  
- KNN-based correction for population-clustered missingness  
- Removal of samples with > 5% missingness  

#### Categorical Encoding
- Genotypes encoded as 0/1/2  
- Ancestry labels one-hot encoded  
- Case/control status encoded for classification  

---

## 6. Feature Engineering

### 6.1 Polygenic Risk Score (PRS)
Primary engineered feature based on:
- GWAS effect sizes  
- Beta coefficients  
- Allele counts  
- Function-weighted variants (optional)

### 6.2 Additional Genomic Features
- Population allele frequencies  
- Functional gene scores  
- Regulatory annotations  

### 6.3 Normalization
Z-score scaling across all engineered features.

---

## 7. Machine Learning Approach

### 7.1 Model Choice: XGBoost Classifier  
Selected for:
- excellent performance on structured genomic matrices,  
- robustness to sparse features,  
- built-in regularization,  
- native handling of class imbalance (scale_pos_weight),  
- strong interpretability through importance scores.

### 7.2 Dataset Complexity Considerations
- **High dimensionality (p >> n)**: 84M variants vs 2504 samples  
- **Population structure confounding**  
- **Extreme sparsity** in variant matrices  
- **Non-linearity** in genotype-phenotype relationships  

XGBoost effectively handles these challenges.

---

## 8. Implementation Plan

### 8.1 Technical Stack

| Component | Libraries |
|----------|-----------|
| Big Data Processing | PySpark (sql, ml, mllib) |
| Machine Learning | XGBoost, scikit-learn |
| Data Manipulation | pandas, numpy, scipy |
| Genomics Tools | pysam, VCF tools |
| Visualization | matplotlib, seaborn, plotly |

### 8.2 Pipeline Steps (Rewritten Clean Version)
1. Distributed loading of VCF files via Spark  
2. Variant and sample quality filtering  
3. Functional annotation  
4. PRS computation  
5. Case/control label creation  
6. Train/test split using stratification  
7. Feature scaling  
8. XGBoost training  
9. Evaluation & interpretation  

---

## 9. Evaluation Framework

### 9.1 Primary Metric
**Precision-Recall AUC**  
Chosen due to:
- high class imbalance in genomic disease prediction  
- clinical importance of avoiding false negatives  

### 9.2 Secondary Metrics
- Recall @ 90% Precision  
- Calibration curves  
- Feature importance  
- Population stratification evaluation  

---

## 10. Limitations
- PRS accuracy varies across ancestries  
- Study limited to 1000 Genomes (not disease-labeled)  
- XGBoost not inherently biological — requires post-hoc interpretation  

---

## 11. Future Work
- Integrate deep learning approaches (e.g., CNNs on variant windows)  
- Expand to multi-omic features (transcriptomics, methylation)  
- Incorporate clinical phenotypes via UK Biobank  
- Deploy real-time PRS dashboards for clinicians  

---

## 12. Conclusion
This work presents a complete, research-grade genomics pipeline capable of processing terabyte-scale variant datasets, performing biologically informed feature engineering, and producing interpretable disease-risk predictions. By combining distributed Big Data processing with machine learning and polygenic scoring, the system provides a scalable foundation for population-wide precision medicine analysis.

---

## 13. References
*Place your scientific references, GWAS sources, and tool citations here.*

